Discover the critical implications of the FDA’s recent classification of cellular analysis systems for antimicrobial susceptibility testing. This course offers in-depth insights into the criteria, special controls, and benefits that ensure device safety and regulatory compliance.
In this course you will learn the following:
* Understand the classification process and criteria for the cellular analysis system.
* Identify the special controls required for compliance.
* Recognize the benefits of the De Novo classification process in reducing regulatory burdens.
FDA’s Classification of Cellular Analysis Systems
$9.99
1 year of access
Course Content
FDA’s Classification of Cellular Analysis Systems
